Denise Scots Knight Mereo Biopharma Group PLC (MREO) insider trading activity

Denise Scots Knight is Chief Executive Officer of Mereo Biopharma Group plc. Currently has a direct ownership of 808,921 shares of MREO, which is worth approximately $2.33 Million. The most recent transaction as insider was on Sep 13, 2024, when has been sold 60,046 shares (American Depositary Shares representing Ordinary Shares) at a price of $4.22 per share, resulting in proceeds of $253,394. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 809K

0% 3M change

n/a 12M change

Total Value Held $2.33 Million

Denise Scots-Knight Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 13 2024	SELL Open market or private sale	$253,394 $4.22 p/Share	60,046 Reduced 6.91%	808,921 American Depositary Sh...
Sep 12 2024	SELL Open market or private sale	$127,891 $4.47 p/Share	28,611 Reduced 3.19%	868,967 American Depositary Sh...
Sep 11 2024	BUY Exercise of conversion of derivative security	-	188,060 Added 17.32%	897,578 American Depositary Sh...
Jun 26 2024	SELL Open market or private sale	$312,805 $3.39 p/Share	92,273 Reduced 11.51%	709,518 American Depositary Sh...
Jun 25 2024	SELL Open market or private sale	$150,227 $3.69 p/Share	40,712 Reduced 4.83%	801,791 American Depositary Sh...
Jun 21 2024	BUY Exercise of conversion of derivative security	-	282,090 Added 25.08%	842,503 American Depositary Sh...

Also insider at

ELAN

Elanco Animal Health Inc Healthcare